Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
Authors
Keywords
Triple-negative breast cancer, IDC, DCIS, Basal type breast cancer, Androgen receptor, Steroid metabolism
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 145, Issue 2, Pages 281-293
Publisher
Springer Nature
Online
2014-04-09
DOI
10.1007/s10549-014-2942-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
- (2013) Keely M. McNamara et al. CANCER SCIENCE
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Amplitude modulation of androgen signaling by c-MYC
- (2013) M. Ni et al. GENES & DEVELOPMENT
- Androgen receptor in triple negative breast cancer
- (2012) K.M. McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
- (2012) T. E. Hickey et al. MOLECULAR ENDOCRINOLOGY
- InSilico DB genomic datasets hub: an efficient starting point for analyzing genome-wide studies in GenePattern, Integrative Genomics Viewer, and R/Bioconductor
- (2012) Alain Coletta et al. GENOME BIOLOGY
- Expression and clinical significance of androgen receptor in triple negative breast cancer
- (2012) Xiang Luo et al. Chinese Journal of Cancer
- Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
- (2012) Jenny J. Schulze et al. Frontiers in Pharmacology
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Triple-negative breast cancer: Histological subtypes and immunohistochemical and clinicopathological features
- (2011) Yuko Ishikawa et al. CANCER SCIENCE
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
- (2011) Jin Li et al. PLoS One
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- Breast Cancer Subtypes and the Risk of Local and Regional Relapse
- (2010) K. David Voduc et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates
- (2010) Minoru Miyashita et al. VIRCHOWS ARCHIV
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast
- (2008) R. Shibuya et al. ENDOCRINE-RELATED CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation